Dsc Advisors, L.P. Danaher Corp Transaction History

Dsc Advisors, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $91,906 - $560,752	-372 Reduced 29.45%	891 $230,000
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $11,855 - $14,983	-50 Reduced 3.81%	1,263 $320,000
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $156,677 - $192,297	609 Added 86.51%	1,313 $385,000
Q4 2021 Feb 14, 2022	SELL	$292.08 - $329.01 $9,346 - $10,528	-32 Reduced 4.35%	704 $232,000
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $200,346 - $244,668	736 New	736 $224,000
Q2 2021 Aug 16, 2021	SELL	$225.08 - $271.69 $229,131 - $276,580	-1,018 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$212.38 - $245.9 $216,202 - $250,326	1,018 New	1,018 $229,000
Q1 2020 May 15, 2020	SELL	$121.39 - $169.05 $225,906 - $314,602	-1,861 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$133.47 - $153.48 $46,047 - $52,950	345 Added 22.76%	1,861 $286,000
Q3 2019 Nov 14, 2019	BUY	$135.4 - $146.47 $205,266 - $222,048	1,516 New	1,516 $219,000

2,432

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Dsc Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Dsc Advisors, L.P. with notifications on news.